3D打印矫形器设计、制造、使用标准与全流程监管的专家共识

2018-01-30 中国骨科相关专家小组(统称) 中华创伤骨科杂志,2018,20(1):5-9.

3D打印技术又称为快速成型技术,是以数字模型文件为基础,通过逐层打印的方式来构造物体的一种快速成型加工方式,具有材料利用率高、易于制造复杂结构等特点。自1986年制造了第一台3D打印机以来,3D打印的应用越来越广泛,价格也逐年降低。矫形器作为一种与人体密切接触的康复辅助器具,个性化设计和制造尤为必要。随着计算机辅助设计技术和3D打印技术的发展,个性化设计和制造矫形器成为可能。与传统制作矫形器的方式

中文标题:

3D打印矫形器设计、制造、使用标准与全流程监管的专家共识

发布日期:

2018-01-30

简要介绍:

3D打印技术又称为快速成型技术,是以数字模型文件为基础,通过逐层打印的方式来构造物体的一种快速成型加工方式,具有材料利用率高、易于制造复杂结构等特点。自1986年制造了第一台3D打印机以来,3D打印的应用越来越广泛,价格也逐年降低。矫形器作为一种与人体密切接触的康复辅助器具,个性化设计和制造尤为必要。随着计算机辅助设计技术和3D打印技术的发展,个性化设计和制造矫形器成为可能。与传统制作矫形器的方式相比,3D打印技术与数字化医疗相结合应用于矫形器的制作不仅与人体结构更加贴合,而且提高了材料的利用率,外型也更加美观,实现了加工环境的友好化。3D打印技术联合生物力学分析等技术,可以设计出更加符合生物力学的矫形器。越来越多的3D打印矫形器被应用于治疗患者。

3D打印矫形器的研究范围包括结构、材料、临床效果等,作为一种新技术被应用于矫形器的制作,其相关标准的制定也是一件急需解决的事情。就国内外针对3D打印矫形器标准的制定所做的工作来分析,首先以美国为例,为推动制造产业的创新发展,奥巴马政府2012年8月成立了美国增材制造创新研究所,2013年10月该研究所正式更名为"美国制造"(America Makes),至今共开展了3批合作项目。在"美国制造"第3批项目列表中,由密歇根大学牵头的3D打印踝足矫形器的设计与材料应用项目入选。欧洲3D打印技术平台(AM Platform)在2012年至2014年期间发布了多版3D打印战略研究报告,为整个欧盟3D打印技术的进步和产业发展提供了指导框架。本标准的制定可为国内3D打印矫形器的应用提供参考,进一步完善现有的康复辅具法规。

 

拓展指南:3D打印相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=3D打印矫形器设计、制造、使用标准与全流程监管的专家共识)] GetToolGuiderByIdResponse(projectId=1, id=345f11c001555253, title=3D打印矫形器设计、制造、使用标准与全流程监管的专家共识, enTitle=, guiderFrom=中华创伤骨科杂志,2018,20(1):5-9., authorId=null, author=, summary=3D打印技术又称为快速成型技术,是以数字模型文件为基础,通过逐层打印的方式来构造物体的一种快速成型加工方式,具有材料利用率高、易于制造复杂结构等特点。自1986年制造了第一台3D打印机以来,3D打印的应用越来越广泛,价格也逐年降低。矫形器作为一种与人体密切接触的康复辅助器具,个性化设计和制造尤为必要。随着计算机辅助设计技术和3D打印技术的发展,个性化设计和制造矫形器成为可能。与传统制作矫形器的方式, cover=, journalId=null, articlesId=null, associationId=717, associationName=中国骨科相关专家小组(统称), associationIntro=本制定者非特指某个专家小组,为统称。, copyright=0, guiderPublishedTime=Tue Jan 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>3D打印技术又称为快速成型技术,是以数字模型文件为基础,通过逐层打印的方式来构造物体的一种快速成型加工方式,具有材料利用率高、易于制造复杂结构等特点。自1986年制造了第一台3D打印机以来,3D打印的应用越来越广泛,价格也逐年降低。矫形器作为一种与人体密切接触的康复辅助器具,个性化设计和制造尤为必要。随着计算机辅助设计技术和3D打印技术的发展,个性化设计和制造矫形器成为可能。与传统制作矫形器的方式相比,3D打印技术与数字化医疗相结合应用于矫形器的制作不仅与人体结构更加贴合,而且提高了材料的利用率,外型也更加美观,实现了加工环境的友好化。3D打印技术联合生物力学分析等技术,可以设计出更加符合生物力学的矫形器。越来越多的3D打印矫形器被应用于治疗患者。 <BR><BR>3D打印矫形器的研究范围包括结构、材料、临床效果等,作为一种新技术被应用于矫形器的制作,其相关标准的制定也是一件急需解决的事情。就国内外针对3D打印矫形器标准的制定所做的工作来分析,首先以美国为例,为推动制造产业的创新发展,奥巴马政府2012年8月成立了美国增材制造创新研究所,2013年10月该研究所正式更名为"美国制造"(America Makes),至今共开展了3批合作项目。在"美国制造"第3批项目列表中,由密歇根大学牵头的3D打印踝足矫形器的设计与材料应用项目入选。欧洲3D打印技术平台(AM Platform)在2012年至2014年期间发布了多版3D打印战略研究报告,为整个欧盟3D打印技术的进步和产业发展提供了指导框架。本标准的制定可为国内3D打印矫形器的应用提供参考,进一步完善现有的康复辅具法规。</P> <P> </P>拓展指南:<strong>与<font color=red>3D打印</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=ed3761c001ae68d2" title="3D打印骨科模型技术标准专家共识" target=_blank>3D打印骨科模型技术标准专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=70c481c001ae3971" title="3D打印非共面模板辅助CT引导放射性125I粒子植入治疗技术流程与QC的专家共识" target=_blank>3D打印非共面模板辅助CT引导放射性125I粒子植入治疗技术流程与QC的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=af7f51c001ae29fe" title="3D打印模板辅助CT引导放射性125I粒子植入治疗肿瘤专家共识" target=_blank>3D打印模板辅助CT引导放射性125I粒子植入治疗肿瘤专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=3D%E6%89%93%E5%8D%B0" target=_blank>有关3D打印更多指南</a></ul>, tagList=[TagDto(tagId=15673, tagName=3D打印), TagDto(tagId=19704, tagName=矫形器)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5429, appHits=73, showAppHits=0, pcHits=3869, showPcHits=2239, likes=157, shares=2, comments=5, approvalStatus=1, publishedTime=Wed Feb 14 20:20:03 CST 2018, publishedTimeString=2018-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 14 20:20:03 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 20:49:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=3D打印矫形器设计、制造、使用标准与全流程监管的专家共识)])
3D打印矫形器设计、制造、使用标准与全流程监管的专家共识
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2102745, encodeId=d4a22102e45c3, content=有用,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97288450456, createdName=ms6000000447315683, createdTime=Sat Nov 26 13:14:52 CST 2022, time=2022-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=289486, encodeId=736e2894869d, content=受益匪浅.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Feb 20 19:11:31 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288406, encodeId=fc3528840690, content=学习.受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:22 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288405, encodeId=3240288405b7, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:08 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287962, encodeId=d11528e96294, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Wed Feb 14 20:30:31 CST 2018, time=2018-02-14, status=1, ipAttribution=)]
    2022-11-26 ms6000000447315683 来自四川省

    有用,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2102745, encodeId=d4a22102e45c3, content=有用,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97288450456, createdName=ms6000000447315683, createdTime=Sat Nov 26 13:14:52 CST 2022, time=2022-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=289486, encodeId=736e2894869d, content=受益匪浅.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Feb 20 19:11:31 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288406, encodeId=fc3528840690, content=学习.受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:22 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288405, encodeId=3240288405b7, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:08 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287962, encodeId=d11528e96294, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Wed Feb 14 20:30:31 CST 2018, time=2018-02-14, status=1, ipAttribution=)]
    2018-02-20 虈亣靌

    受益匪浅.谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2102745, encodeId=d4a22102e45c3, content=有用,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97288450456, createdName=ms6000000447315683, createdTime=Sat Nov 26 13:14:52 CST 2022, time=2022-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=289486, encodeId=736e2894869d, content=受益匪浅.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Feb 20 19:11:31 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288406, encodeId=fc3528840690, content=学习.受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:22 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288405, encodeId=3240288405b7, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:08 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287962, encodeId=d11528e96294, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Wed Feb 14 20:30:31 CST 2018, time=2018-02-14, status=1, ipAttribution=)]
    2018-02-16 131****1460

    学习.受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2102745, encodeId=d4a22102e45c3, content=有用,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97288450456, createdName=ms6000000447315683, createdTime=Sat Nov 26 13:14:52 CST 2022, time=2022-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=289486, encodeId=736e2894869d, content=受益匪浅.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Feb 20 19:11:31 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288406, encodeId=fc3528840690, content=学习.受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:22 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288405, encodeId=3240288405b7, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:08 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287962, encodeId=d11528e96294, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Wed Feb 14 20:30:31 CST 2018, time=2018-02-14, status=1, ipAttribution=)]
    2018-02-16 131****1460

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2102745, encodeId=d4a22102e45c3, content=有用,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97288450456, createdName=ms6000000447315683, createdTime=Sat Nov 26 13:14:52 CST 2022, time=2022-11-26, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=289486, encodeId=736e2894869d, content=受益匪浅.谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Feb 20 19:11:31 CST 2018, time=2018-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288406, encodeId=fc3528840690, content=学习.受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:22 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288405, encodeId=3240288405b7, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Fri Feb 16 13:53:08 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=287962, encodeId=d11528e96294, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/30/21f1f0d02514796066d52523c747be51.jpg, createdBy=75a31960463, createdName=zdvfsadb, createdTime=Wed Feb 14 20:30:31 CST 2018, time=2018-02-14, status=1, ipAttribution=)]
    2018-02-14 zdvfsadb

    学习了

    0